Annual report of the Australian National Poliovirus Reference Laboratory, 2002

Bruce R Thorley1, Kerri Anne Brussen, Vicki Stambos

  • 1Poliovirus Reference Laboratory, Carlton South, Victoria. bruce.thorley@mh.org.au

Insights

In 2002, Australian laboratories detected Sabin-like poliovirus and other enteroviruses in patients with acute flaccid paralysis. Continued surveillance and high vaccination coverage are crucial for preventing poliovirus re-introduction.

Area of Science:

  • Virology
  • Public Health
  • Epidemiology

Background:

  • Acute flaccid paralysis (AFP) is the primary symptom of poliomyelitis.
  • Australia has been declared free of endemic wild poliovirus since October 2000.
  • Poliomyelitis remains endemic in three World Health Organization (WHO) regions, posing a re-introduction risk.

Purpose of the Study:

  • To investigate poliovirus and enterovirus detections in Australian cases of acute flaccid paralysis in 2002.
  • To assess the ongoing need for surveillance and vaccination in Australia.
  • To monitor the global poliomyelitis eradication progress.

Main Methods:

  • Faecal specimens from AFP cases were cultured for poliovirus at the National Poliovirus Reference Laboratory.
  • Isolates were tested to differentiate between Sabin oral polio vaccine strains and wild-type polioviruses.
  • Non-polio enteroviruses were also identified.

Main Results:

  • A Sabin-like poliovirus type 3 was isolated from an Australian AFP patient.
  • Echovirus type 18, a non-polio enterovirus, was identified in another AFP case.
  • The laboratory identified 35 Sabin-like polioviruses from 52 specimens, including those from non-AFP cases.

Conclusions:

  • Despite being polio-free, Australia faces a risk of wild poliovirus re-introduction.
  • Maintaining high poliovirus vaccination coverage and AFP surveillance is essential.
  • Global eradication efforts are ongoing, with increased wild poliovirus detections in some regions in 2002.